These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30617817)

  • 1. Development of an efficient neutralization assay for Coxsackievirus A10.
    Liu D; Xu L; Zhu R; Yin Z; Lin Y; Hou W; Li S; He S; Cheng T; Xia N
    Appl Microbiol Biotechnol; 2019 Feb; 103(4):1931-1938. PubMed ID: 30617817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a coxsackievirus A16 neutralization test based on the enzyme-linked immunospot assay.
    Hou W; Yang L; He D; Zheng J; Xu L; Liu J; Liu Y; Zhao H; Ye X; Cheng T; Xia N
    J Virol Methods; 2015 Apr; 215-216():56-60. PubMed ID: 25704596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice.
    Dai W; Xiong P; Zhang X; Liu Z; Chen J; Zhou Y; Ye X; Zhang C
    Antiviral Res; 2019 Apr; 164():139-146. PubMed ID: 30817941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an enzyme-linked immunosorbent spot assay to measure serum-neutralizing antibodies against coxsackievirus B3.
    Yang L; He D; Tang M; Li Z; Liu C; Xu L; Chen Y; Du H; Zhao Q; Zhang J; Cheng T; Xia N
    Clin Vaccine Immunol; 2014 Mar; 21(3):312-20. PubMed ID: 24391137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
    Zhang Z; Dong Z; Li J; Carr MJ; Zhuang D; Wang J; Zhang Y; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum.
    Jin J; Ma H; Xu L; An D; Sun S; Huang X; Kong W; Jiang C
    J Virol Methods; 2013 Feb; 187(2):362-7. PubMed ID: 23178532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge.
    Shen C; Liu Q; Zhou Y; Ku Z; Wang L; Lan K; Ye X; Huang Z
    Vaccine; 2016 Sep; 34(41):5005-5012. PubMed ID: 27562093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a high-throughput assay for measuring serum neutralizing antibody against enterovirus 71.
    Huang ML; Chiang PS; Luo ST; Liou GY; Lee MS
    J Virol Methods; 2010 Apr; 165(1):42-5. PubMed ID: 20036286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.
    Zhang Z; Dong Z; Wang Q; Carr MJ; Li J; Liu T; Li D; Shi W
    Vaccine; 2018 Nov; 36(46):7095-7104. PubMed ID: 30316529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a rapid neutralization assay for the detection of neutralizing antibodies against coxsackievirus B1.
    Wu Y; Yin Z; Zhu R; Xu L; Huang Q; Zhang D; Yang H; Zhou Z; Zhang J; Cheng T; Xia N
    Diagn Microbiol Infect Dis; 2022 Jun; 103(2):115676. PubMed ID: 35405611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
    Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
    Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Neutralizing Antibodies Against Candidate Serotypes of
    Kim S; Bae KS; Kim JH; Kang JH; Choi UY
    Viral Immunol; 2021 Mar; 34(2):62-67. PubMed ID: 33030408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system.
    Lien SC; Shen YS; Lin HY; Wu SR; Fang CY; Chen CH; Chen YA; Chong PC; Huang MH; Chow YH; Wang JR; Wu SC; Liu CC
    Virus Res; 2023 May; 329():199101. PubMed ID: 36958398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Neutralization Testing System for Zika Virus Based on an Enzyme-Linked Immunospot Assay.
    Li S; Zhao H; Yang H; Hou W; Cruz-Cosme R; Cao R; Chen C; Wang W; Xu L; Zhang J; Zhong W; Xia N; Tang Q; Cheng T
    ACS Infect Dis; 2020 May; 6(5):811-819. PubMed ID: 31840495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10.
    Zhu R; Xu L; Zheng Q; Cui Y; Li S; He M; Yin Z; Liu D; Li S; Li Z; Chen Z; Yu H; Que Y; Liu C; Kong Z; Zhang J; Baker TS; Yan X; Hong Zhou Z; Cheng T; Xia N
    Sci Adv; 2018 Sep; 4(9):eaat7459. PubMed ID: 30255146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine.
    Gao W; Yue L; Yang T; Shen D; Li H; Song X; Xie T; He X; Xie Z
    Biomed Pharmacother; 2021 Nov; 143():112212. PubMed ID: 34649345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.
    Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS
    Virol J; 2016 Mar; 13():44. PubMed ID: 26987753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand.
    Lerdsamran H; Prasertsopon J; Mungaomklang A; Klinmalai C; Noisumdaeng P; Sangsiriwut K; Tassaneetrithep B; Guntapong R; Iamsirithaworn S; Puthavathana P
    Virol J; 2018 Oct; 15(1):158. PubMed ID: 30326914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VP2 residue N142 of coxsackievirus A10 is critical for the interaction with KREMEN1 receptor and neutralizing antibodies and the pathogenicity in mice.
    Li X; Liu Z; Yan X; Tian Y; Liu K; Zhao Y; Shao J; Hao P; Zhang C
    PLoS Pathog; 2023 Oct; 19(10):e1011662. PubMed ID: 37788227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a rapid neutralization testing system for Rhinovirus C15 based on the enzyme-linked immunospot assay.
    Zhou Z; Zhu R; Yang H; Xu L; Chen H; Wu Y; Yin Z; Huang Q; Zhang D; Liu C; Que Y; Zhang J; Xia N; Cheng T
    Front Microbiol; 2022; 13():983656. PubMed ID: 36212859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.